[ad_1]
In Europe, Germany is beating everyone on the clock and announces that the coronavirus vaccination campaign will start in mid-December. Ultimately, as soon as the European authorities that control drugs approve a vaccine, the Germans will be able to access it with “6 vaccination centers ready in the landing modules from mid-December,” said Health Minister Jens Spahn . And in Italy? The timing of the Covid vaccination plan is at the end of January for the first vaccinations, but it has not been decided whether the vaccine should be mandatory or not. Yesterday the emergency commissioner Domenico Arcuri: “So far we have spent 94 million euros. We estimate that there should be one vaccine administration and storage point for every 20-30 thousand inhabitants. In the coming weeks, Parliament will decide on the strategy …
In Europe the Germany defeats everyone in time and announces that the vaccination campaign against Coronavirus It will start in mid December. Ultimately, as soon as the European authorities that control medicines approve a vaccine, the Germans will be able to access it with “6 vaccination centers ready for landing since mid-December, “said Health Minister Jens Spahn. And in Italy? The timing of the vaccination plan anti Covid Talk about end of january for the first vaccines, but it has not been decided whether the vaccine should be mandatory or not. Yesterday the emergency commissioner Domenico Arcuri: “So far we have spent 94 million euros. We estimate that there should be a vaccine administration and storage point for every 20-30 thousand inhabitants. In the coming weeks, Parliament will decide the strategy proposed by the government.”
Meanwhile they are three main vaccines closest to receiving authorization: that of the multinational AstraZeneca with the Jenner Institute of the University of Oxford and the Irbm of Pomezia, that of the American pharmacist Modern and that of the multinational Pzifer. But the whole world is in the race for the vaccine and, according to WHO data, there are 212 vaccines in the testing process, 164 are still in the preclinical phase and 48 are administered to volunteers. In the group of those in the pipeline are also the Russians and the Chinese: Sputnik V of the Gamaleya Institute in Moscow, with a declared effectiveness of 93.5% and the Chinese Coronavac, whose experimentation has suffered an arrest beat after the suicide of a volunteer in Brazil.
Pfizer
The American drug Pfizer, developed together with the German BioNtech, is called BNT162 and it would be 95% effective. It is a vaccine a MRNA, a technique that involvesinoculation of a synthetic gene that pushes the body to produce the protein spike of Covid-19, in this way the immune system recognizes it as a foreign agent and produces the necessary antibodies. But it goes stored at -80 degreesIt is not an easy condition without ad hoc instrumentation. It must be administered in two doses. There European Comission signed a contract to have up to 300 million doses. The two companies will be able to supply 50 million doses in 2020 and up to 1.3 billion in 2021. 3.4 million doses in total will be administered to the first 1.7 million Italians from the end of January according to the Anti-Vaccine Plan. -Covid of Commissioner Arcuri.
Modern
The vaccine MRNA-1273 developed by american Modern Inc and Niad would have an efficiency of 94.5%. It was the first to be tested in humans on March 16. The technology used is the same as the Pfizer vaccine, but you don’t need it Cold chain and can be stored between 2nd and 8th degrees in the first month already -20 ° during the following six months. The company expects to have around 20 million doses by the end of 2020 for the US and plans a total production of 500 million-1 billion doses in 2021. The European Commission has agreed with Moderna to supply up to 160 million doses. . The expected cost per dose is $ 25.
Astrazeneca
Another candidate to become the Covid vaccine is ChAdOx1 o AZD1222, developed by the Jenner Institute at the University of Oxford together with the Italian Advent-Irbm and the pharmaceutical company AstraZeneca. The preparation is different, it is based on an artificial and inactivated adenovirus that is used as a transport container for the Spike protein: once injected, the immune system recognizes the foreign protein and develops neutralizing antibodies. The vaccine can be stored for up to 6 months at normal refrigeration temperatures an 2-8 degree centigrade. AstraZeneca announced yesterday the efficacy data on the optimal dose, in two doses tested, which is equal to 90%. The company announced that 200 million doses will be available by 2020 and 3 billion doses in 2021. The European Commission has opted for a total of 400 million doses.
© All rights reserved
